ArticleRadiation oncology journal2025

Feasibility and safety study of ultra-hypofractionated neoadjuvant radiotherapy to margins-at-risk in retroperitoneal sarcoma.

Ru-Xin Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.